-
公开(公告)号：US20140377298A1
公开(公告)日：2014-12-25
申请号：US14483097
申请日：2014-09-10
Applicant: Vicky FACHINGER , Knut ELBERS , Axel LISCHEWSKI , Marion KIXMOELLER , Francois-Xavier ORVEILLON , Isabelle FREIIN VON RICHTHOFEN , Michael D. PIONTKOWSKI
Inventor： Vicky FACHINGER , Knut ELBERS , Axel LISCHEWSKI , Marion KIXMOELLER , Francois-Xavier ORVEILLON , Isabelle FREIIN VON RICHTHOFEN , Michael D. PIONTKOWSKI
CPC classification number: A61K39/12 , A61K31/155 , A61K31/7036 , A61K2039/5252 , A61K2039/545 , A61K2039/55 , A61K2039/552 , A61K2039/55555 , C12N7/00 , C12N2750/10034
Abstract: The present invention relates to a method for the treatment or prophylaxis of a PCV2 infection or for reduction of clinical symptoms caused by or associated with a PCV2 infection in animals a) having anti-PCV2 antibodies and/or b) being young piglets of 1 to 22 days of age, comprising the step of administering an effective amount of a PCV2 antigen to that animal in need of such treatment. Preferably, those animals are pigs or young piglets.
Abstract translation: 本发明涉及一种用于治疗或预防PCV2感染或减少由PCV2感染引起的或与动物相关的临床症状的方法a）具有抗PCV2抗体和/或b）是1至 22天龄，包括向需要这种治疗的动物施用有效量的PCV2抗原的步骤。 优选地，这些动物是猪或幼仔。
-
公开(公告)号：US20090010954A1
公开(公告)日：2009-01-08
申请号：US12030611
申请日：2008-02-13
Applicant: Vicky Fachinger , Knut Elbers , Marion Kixmoeller , Francois-Xavier Orveillon , Isabelle Von Richthofen , Axel Lischewski
Inventor： Vicky Fachinger , Knut Elbers , Marion Kixmoeller , Francois-Xavier Orveillon , Isabelle Von Richthofen , Axel Lischewski
CPC classification number: A61K39/12 , A61K2039/5252 , A61K2039/5256 , A61K2039/552 , C12N7/00 , C12N2710/14041 , C12N2710/14043 , C12N2710/14143 , C12N2750/10034 , C12N2750/10071
Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.
Abstract translation: 本发明涉及包含猪圆环病毒2型（PCV2）抗原的免疫原性组合物在动物，优选猪中预防和治疗亚临床PCV2感染的用途。
-
公开(公告)号：US09534207B2
公开(公告)日：2017-01-03
申请号：US14281287
申请日：2014-05-19
Applicant: Kim Burgard , Jeremy Kroll , Sarah M. Layton , Volker Ohlinger , Francois-Xavier Orveillon , Stefan Pesch , Michael Dennis Piontkowski , Michael B. Roof , Philip Utley , Eric Martin Vaughn
Inventor： Kim Burgard , Jeremy Kroll , Sarah M. Layton , Volker Ohlinger , Francois-Xavier Orveillon , Stefan Pesch , Michael Dennis Piontkowski , Michael B. Roof , Philip Utley , Eric Martin Vaughn
IPC: A61K39/225 , C12N7/00 , A61K39/12 , A61K38/00 , A61K39/00
CPC classification number: A61K39/12 , A61K2039/5254 , A61K2039/53 , A61K2039/552 , A61K2039/575 , C12N7/00 , C12N2770/10021 , C12N2770/10034 , C12N2770/10064 , C12N2770/10071
Abstract: The present invention is related to improved modified live PRRS vaccines containing new PRRSV European strains of PRRSV and methods of use and manufacture of such vaccines.
Abstract translation: 本发明涉及包含新的PRRSV欧洲PRRSV菌株的改良的活的PRRS疫苗，以及使用和制造这种疫苗的方法。
-
公开(公告)号：US20130115236A1
公开(公告)日：2013-05-09
申请号：US13729688
申请日：2012-12-28
Applicant: Vicky FACHINGER , Knut ELBERS , Marion KIXMOELLER , Francois-Xavier ORVEILLON , Isabelle FREIIN VON RICHTHOFEN , Axel LISCHEWSKI
Inventor： Vicky FACHINGER , Knut ELBERS , Marion KIXMOELLER , Francois-Xavier ORVEILLON , Isabelle FREIIN VON RICHTHOFEN , Axel LISCHEWSKI
IPC: A61K39/12
CPC classification number: A61K39/12 , A61K2039/5256 , A61K2039/545 , A61K2039/552 , A61K2039/55555 , C12N7/00 , C12N2710/14043 , C12N2750/10022 , C12N2750/10034
Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment, including a reduction in the severity of, duration of, and manifestations of, porcine respiratory disease complex (PRDC) in animals, preferably in pigs.
-
公开(公告)号：US20120213810A1
公开(公告)日：2012-08-23
申请号：US13396298
申请日：2012-02-14
Applicant: Kim BURGARD , Jeremy KROLL , Sarah M. LAYTON , Volker OHLINGER , Francois-Xavier ORVEILLON , Stefan PESCH , Michael Dennis PIONTKOWSKI , Michael B. ROOF , Philip UTLEY , Eric Martin VAUGHN
Inventor： Kim BURGARD , Jeremy KROLL , Sarah M. LAYTON , Volker OHLINGER , Francois-Xavier ORVEILLON , Stefan PESCH , Michael Dennis PIONTKOWSKI , Michael B. ROOF , Philip UTLEY , Eric Martin VAUGHN
CPC classification number: A61K39/12 , A61K2039/5254 , A61K2039/53 , A61K2039/552 , A61K2039/575 , C12N7/00 , C12N2770/10021 , C12N2770/10034 , C12N2770/10064 , C12N2770/10071
Abstract: The present invention is related to improved modified live PRRS vaccines containing new PRRSV European strains of PRRSV and methods of use and manufacture of such vaccines.
Abstract translation: 本发明涉及包含新的PRRSV欧洲PRRSV菌株的改良的活的PRRS疫苗，以及使用和制造这种疫苗的方法。
-
Patent Agency Ranking
公开(公告)号：US20110091499A1
公开(公告)日：2011-04-21
申请号：US12519135
申请日：2007-12-14
Applicant: Vicky Fachinger , Knut Elbers , Axel Lischewski , Marion Kixmoeller , Francois-Xavier Orveillon , Isabelle Freiin Von Richthofen , Michael Piontkowski
Inventor： Vicky Fachinger , Knut Elbers , Axel Lischewski , Marion Kixmoeller , Francois-Xavier Orveillon , Isabelle Freiin Von Richthofen , Michael Piontkowski
CPC classification number: A61K39/12 , A61K31/155 , A61K31/7036 , A61K2039/5252 , A61K2039/545 , A61K2039/55 , A61K2039/552 , A61K2039/55555 , C12N7/00 , C12N2750/10034
Abstract: The present invention relates to a method for the treatment or prophylaxis of a PCV2 infection or for reduction of clinical symptoms caused by or associated with a PCV2 infection in animals a) having anti-PCV2 antibodies and/or b) being young piglets of 1 to 22 days of age, comprising the step of administering an effective amount of a PCV2 antigen to that animal in need of such treatment. Preferably, those animals are pigs or young piglets.
Abstract translation: 本发明涉及一种用于治疗或预防PCV2感染或减少由PCV2感染引起的或与动物相关的临床症状的方法a）具有抗PCV2抗体和/或b）是1至 22天龄，包括向需要这种治疗的动物施用有效量的PCV2抗原的步骤。 优选地，这些动物是猪或幼仔。
-
公开(公告)号：US20140255442A1
公开(公告)日：2014-09-11
申请号：US14281287
申请日：2014-05-19
Applicant: Kim BURGARD , Jeremy KROLL , Sarah M. LAYTON , Volker OHLINGER , Francois-Xavier ORVEILLON , Stefan PESCH , Michael Dennis PIONTKOWSKI , Michael B. ROOF , Philip UTLEY , Eric Martin VAUGHN
Inventor： Kim BURGARD , Jeremy KROLL , Sarah M. LAYTON , Volker OHLINGER , Francois-Xavier ORVEILLON , Stefan PESCH , Michael Dennis PIONTKOWSKI , Michael B. ROOF , Philip UTLEY , Eric Martin VAUGHN
IPC: C12N7/00
CPC classification number: A61K39/12 , A61K2039/5254 , A61K2039/53 , A61K2039/552 , A61K2039/575 , C12N7/00 , C12N2770/10021 , C12N2770/10034 , C12N2770/10064 , C12N2770/10071
Abstract: The present invention is related to improved modified live PRRS vaccines containing new PRRSV European strains of PRRSV and methods of use and manufacture of such vaccines.
Abstract translation: 本发明涉及包含新的PRRSV欧洲PRRSV菌株的改良的活的PRRS疫苗，以及使用和制造这种疫苗的方法。
-
公开(公告)号：US08765142B2
公开(公告)日：2014-07-01
申请号：US13396298
申请日：2012-02-14
Applicant: Kim Burgard , Jeremy Kroll , Sarah M. Layton , Volker Ohlinger , Francois-Xavier Orveillon , Stefan Pesch , Michael Dennis Piontkowski , Michael B. Roof , Philip Utley , Eric Martin Vaughn
Inventor： Kim Burgard , Jeremy Kroll , Sarah M. Layton , Volker Ohlinger , Francois-Xavier Orveillon , Stefan Pesch , Michael Dennis Piontkowski , Michael B. Roof , Philip Utley , Eric Martin Vaughn
IPC: A61K39/225 , A61K38/00
CPC classification number: A61K39/12 , A61K2039/5254 , A61K2039/53 , A61K2039/552 , A61K2039/575 , C12N7/00 , C12N2770/10021 , C12N2770/10034 , C12N2770/10064 , C12N2770/10071
Abstract: The present invention is related to improved modified live PRRS vaccines containing new PRRSV European strains of PRRSV and methods of use and manufacture of such vaccines.
Abstract translation: 本发明涉及包含新的PRRSV欧洲PRRSV菌株的改良的活的PRRS疫苗，以及使用和制造这种疫苗的方法。
-
公开(公告)号：US08496940B2
公开(公告)日：2013-07-30
申请号：US13079498
申请日：2011-04-04
Applicant: Vicky Fachinger , Knut Elbers , Marion Kixmoeller , Francois-Xavier Orveillon , Isabelle von Richthofen , Axel Lischewski
Inventor： Vicky Fachinger , Knut Elbers , Marion Kixmoeller , Francois-Xavier Orveillon , Isabelle von Richthofen , Axel Lischewski
CPC classification number: A61K39/12 , A61K2039/5252 , A61K2039/5256 , A61K2039/552 , C12N7/00 , C12N2710/14041 , C12N2710/14043 , C12N2710/14143 , C12N2750/10034 , C12N2750/10071
Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.
-
公开(公告)号：US07943298B2
公开(公告)日：2011-05-17
申请号：US12030611
申请日：2008-02-13
Applicant: Vicky Fachinger , Knut Elbers , Marion Kixmoeller , Francois-Xavier Orveillon , Isabelle Von Richthofen , Axel Lischewski
Inventor： Vicky Fachinger , Knut Elbers , Marion Kixmoeller , Francois-Xavier Orveillon , Isabelle Von Richthofen , Axel Lischewski
IPC: C12Q1/70
CPC classification number: A61K39/12 , A61K2039/5252 , A61K2039/5256 , A61K2039/552 , C12N7/00 , C12N2710/14041 , C12N2710/14043 , C12N2710/14143 , C12N2750/10034 , C12N2750/10071
Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.
Abstract translation: 本发明涉及包含猪圆环病毒2型（PCV2）抗原的免疫原性组合物在动物，优选猪中预防和治疗亚临床PCV2感染的用途。
-
-
-
-
-
-
-
-
-
Search Results
18
records
(took 0.023 seconds)
